… We undertook this study to evaluate the potential benefit of implementing a CHF disease
management program at a tertiary care center. We wanted to evaluate the benefit in terms of …

… found that the clinical benefit of dapagliflozin for reducing the risk of cardiovascular death
or worsening HF was rapidly apparent, with a sustained statistically significant benefit as soon …

… In this observational cohort study we sought to determine whether an equivalent benefit is
achieved in all HF patients treated in specialized heart failure clinics. Patients were stratified to …

… provides a brief review of acute cardiorenal pathophysiology, the rationale for UF, clinical
benefits of the therapy and a concise strategy for its optimal use in advanced heart failure. …

… of one of the largest clinical development programs ever … and SHIFT, showed that heart rate
reduction with ivabradine … , symptomatic angina, or chronic heart failure. The development of …

Background Heart failure (HF) clinics are known to improve outcomes of patients with HF.
Studies have been limited to single, usually tertiary centres whose experience may not apply …

… systolic heart failure due to … clinical importance for patients with heart failure. Additionally,
we present and discuss major ongoing clinical trials of stem cell therapy for chronic heart failure…

… The risk of sudden cardiac death in patients with heart failure has declined over time thanks
to the … To highlight potential changes over time in ICD clinical benefit in primary prevention of …

Objectives : We sought to determine whether there was a relationship between serum
digoxin concentration (SDC), including SDCs typically regarded as low, and clinical efficacy …

… heart failure, with first statistical significance attained within 2 weeks of randomization; these
benefits … and sustained reductions in clinical events in patients with heart failure with mildly …